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Duodenal metastases secondary to lung cancer are very rare and most of the time asymptomatic. When
symptomatic they usually present with bowel obstruction or perforation. We here describe the case of a
68 year-old man with a solitary metastasis in the duodenum from a non-small cell lung carcinoma
(NSCLC). The patient presented with reduced exercise tolerance and iron deﬁciency anemia without
clinical gastrointestinal blood loss. Further investigation showed a tumor in the left upper lung lobe and
a duodenal metastasis for which he received chemotherapy. To the best of our knowledge this is the ﬁrst
case report of iron deﬁciency anemia as initial presentation of a duodenal metastasis from a NSCLC.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Lung cancer is responsible for the majority of cancer-related
death among males worldwide and females in developed coun-
tries. Approximately 50% of these patients develope metastatic
disease [1]. Primary non-small cell lung carcinoma (NSCLC) usually
metastasizes to the mediastinal lymph nodes, liver, brain, adrenal
glands and bone. Spread to the small intestine (with a prevalence
between 2.6 and 10.7%) is uncommon [2]. Duodenal metastases
have been described in only a few case reports.
Most of the small bowel metastases are asymptomatic but au-
topsy studies suggest that asymptomatic metastases may be more
frequent than previously thoughtwith a prevalence up to 4.6% [3,4].
Metastases of the small bowel usually presents with obstruction or
bowel perforation [2]. Gastrointestinal hemorrhage, or anemia
from occult bleeding of small bowel metastases have been
described in a small number of cases of primary NSCLC [5,6]. Even
less common is a metastasis so presenting with no obvious primary
lung tumor [7]. We describe a case of a 68 year-old man withgy, Amphia Hospital, Molen-
Linsen).
Ltd. This is an open access article uanemia as the presenting symptom of a duodenal metastasis from a
primary NSCLC.
2. Case report
A 68-year-old man, with a history of hypertension, vestibular
neuritis and a benign vocal cord polyp, was referred by his General
Practitioner to the outpatients of our Department of Internal
Medicine. He complained of a progressive reduction in his capacity
to exercise probably resulting from an iron deﬁciency (hemoglobin:
7.73 g/dL, mean corpuscular volume: 73 fL, ferritin: 12 mg/L). Lab-
oratory ﬁndings further revealed a creatinine level of 126 mmol/L
for which the cause remains undiscovered.
Patient had noticed bright red blood in the stools likely caused
by known hemorrhoids but never melaena. He had reduced his
cigarette smoking 9 years ago (40 pack-years) to 2 cigars a day.
Examination of the lungs showedweak vesicular breath sounds but
further physical examination was normal.
Gastroduodenoscopy revealed a tumor in the duodenumwhich
was biopsied. On chest roentgenogram amass of 8 cmwas visible in
the left lung apical for which the patient was referred to a pul-
monologist. Additional total body F-18-ﬂuoro-positron emission
tomography (FDG-PET)/computed tomography (CT) scan showed a
solitary circular mass with a diameter of 7.4 cm at the dorsal side ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Blanco-CT and FDG-PET/CT of the thorax showing a circular mass at the dorsal side of the left upper lobe with a diameter of 7.4 cm.
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in the duodenum (Fig. 2). There were no signs of lymph node, liver,
bone or adrenal gland metastases. Shortly after the start of therapy
magnetic resonance imaging (MRI) of the brain was performed
which shows signs of small ischemic events but no clear
metastases.
Histopathological study of CT guided perthoracal needle biopsy
of the tumoral process in the left upper lung showed a poorly
differentiated adenocarcinoma (Fig. 3A). Immunohistochemical
analysis revealed the tumor cells to be positive for cytokeratin 7
and thyroid transcription factor 1 (TTF-1). There was also nuclear
expression in the P53 gene which strongly supported the diagnosis
of a poorly differentiated adenocarcinoma. Cytokeratin 20, CDX2,
P63, S-100 and PSA proved negative.
The histopathological outcomes of the duodenum biopsy
matched the NSCLC (Fig. 3B). Immunohistochemical analysis was
positive for cytokeratin 7, TTF-1 and CEA. Cytokeratin 20, CDX2 and
PSA proved negative. Thus the immunohistochemical proﬁle too,
was comparable with that of the lung tumor, allowing the conclu-
sion to be drawn that the duodenal lesion was a metastatis of the
primary NSCLC. Additional molecular diagnostics of the NSCLC
revealed the tumor was pan-negative.
In conclusion this patient had a pT3N0M1b NSCLC. Induction
chemotherapy consisted of Carboplatin and Pemetrexed in a 3-
week cycle. Carboplatin was chosen because of the reduced kid-
ney function. The patient will receive 2 such cycles after which
evaluation by CT will take place. If response is adequate, resection
of both tumors will be planed.
3. Discussion
Patients diagnosed with metastases in the small bowel from
primary lung cancer are usually asymptomatic [4]. Primary NSCLC
with undiagnosed small bowel metastasis presents typically with
small bowel obstruction or perforation. In most cases rapid tumorFig. 2. Blanco-CT and FGD-PET/CT of the abdomegrowth leads to obstruction, however central tumor necrosis seems
more likely to result in perforation [4]. To the best of our knowledge
this is the ﬁrst case report of a duodenal metastasis from an un-
diagnosed primary NSCLC presenting as iron deﬁciency anemia.
Solitary small bowel metastases of NSCLC are rare. The jejunum
(followed by the ileum), seems to be themost common small bowel
location in the reported cases [8]. Early diagnosis and treatment of
small bowel metastases are difﬁcult because symptoms are absent
or vague. Screening for small bowel metastases using CT of the
abdomen has a low sensitivity. The use of total-body FDG-PET/CT
for staging of lung cancer might increase the detection of gastro-
intestinal metastases [9]. Recent studies discuss the role of FDG-
PET/CT in detecting gastrointestinal metastases from e for
example e lung cancer [10]. At present there is insufﬁcient
knowledge about sensitivity and speciﬁcity of FDG-PET/CT data to
aid diagnose of small bowel metastases.
All NSCLC tumor cell types can produce small intestinal me-
tastases. Adenocarcinoma, large cell carcinoma and squamous cell
carcinoma are suggested to be the most common [5]. Although the
formation of gastrointestinal metastases is commonly considered
to be hematogenous, the precise way these metastases form re-
mains to be determined. Some studies document cancer cells ﬁlling
the lymphatic vessels of the intestine [11]. These cases suggested a
lymphatic route for formation of solitary small bowel metastases.
According to McNeill et al. all his patients with lung cancer and
small bowel metastases had metastases in other organs including
the more common adrenal gland, liver and kidney [12]. This could
indicated that small bowel metastases are a late symptom of lung
cancer and may be a indicator of poor prognosis for metastasized
lung cancer.
Most patients described in the literature with small bowel
metastasis from NSCLC, underwent surgical resection of the small
bowel process or the affected part of the bowel because of life-
threatening complications such as perforation. Fifty-seven case
reports and three retrospective studies included by Di et al. showedn showing a solitary mass in the duodenum.
Fig. 3. Microscopic images of the primary NSCLC (A) and the duodenal metastasis (B). H&E, 400X. A: solid ﬁelds of polymorﬁc epithelial cells with enlarged nucleoli and a large
amount of eosinoﬁlic cytoplasm consistent with NSCLC. B: solid ﬁelds of large polymorﬁc epithelial cells with enlarged eosinoﬁlic nucleoli and a large amount of eosinoﬁlic
cytoplasm, consistent with primary NSCLC.
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vival of more than a year [13]. Survival of patients with small bowel
metastases from NSCLC thus remains uncertain.
4. Conclusion
Duodenal metastases secondary to NSCLC are probably more
frequent than expected, and physicians should always keep this in
mind despite most being asymptomatic. The rarity and variety of
solitary small bowel metastases as shown in the comprehensive
review by Di et al. makes it difﬁcult to analyze these patients in a
randomized controlled trial. Without evidence-based medicine a
tailored approach is important for patients with NSCLC and sus-
pected small bowel metastasis.
Conﬂicts of interest
The authors state that they have no Conﬂict of interest.
References
[1] L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent, A. Jemal, Global
cancer statistics, 2012, CA Cancer J. Clin. 65 (2) (2015) 87e108.
[2] J.Z. Di, J.Y. Peng, Z.G. Wang, Prevalence, clinicopathological characteristics,
treatment, and prognosis of intestinal metastasis of primary lung cancer: a
comprehensive review, Surg. Oncol. 23 (2) (2014) 72e80.[3] L.E. Stenbygaard, J.B. Sorensen, Small bowel metastases in non-small cell lung
cancer, Lung Cancer Amsterdam Neth. 26 (2) (1999) 95e101.
[4] A. Hillenbrand, J. Strater, D. Henne-Bruns, Frequency, symptoms and outcome
of intestinal metastases of bronchopulmonary cancer. Case report and review
of the literature, Int. Semin. Surg. Oncol. 2 (2005) 13.
[5] W. Liu, W. Zhou, W.L. Qi, Y.D. Ma, Y.Y. Xu, Gastrointestinal hemorrhage due to
ileal metastasis from primary lung cancer, World J. Gastroenterol. 21 (11)
(2015) 3435e3440.
[6] E. Hinoshita, H. Nakahashi, K. Wakasugi, S. Kaneko, M. Hamatake,
K. Sugimachi, Duodenal metastasis from large cell carcinoma of the lung:
report of a case, Surg. Today 29 (8) (1999) 799e802.
[7] M.C. Mulder, J.W. Kist, E.C. Consten, P.M. Verheijen, Gastrointestinal metas-
tasis as the ﬁrst presentation of lung carcinoma, Int. J. Colorectal Dis. 27 (6)
(2012) 839e840.
[8] R.A. Garwood, M.D. Sawyer, E.J. Ledesma, E. Foley, J.A. Claridge, A case and
review of bowel perforation secondary to metastatic lung cancer, Am. Surg. 71
(2) (2005) 110e116.
[9] E.A. Usmanij, L.F. de Geus-Oei, J. Bussink, W.J. Oyen, Update on F-18-ﬂuoro-
deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer, Curr.
Opin. Pulm. Med. 21 (4) (2015) 314e321.
[10] C.G. Cronin, J. Scott, A. Kambadakone, O.A. Catalano, D. Sahani, M.A. Blake, et
al., Utility of positron emission tomography/CT in the evaluation of small
bowel pathology, Br. J. Radiol. 85 (1017) (2012) 1211e1221.
[11] N. Ise, H. Kotanagi, M. Morii, O. Yasui, M. Ito, K. Koyama, et al., Small bowel
perforation caused by metastasis from an extra-abdominal malignancy:
report of three cases, Surg. Today 31 (4) (2001) 358e362.
[12] P.M. McNeill, L.D. Wagman, J.P. Neifeld, Small bowel metastases from primary
carcinoma of the lung, Cancer 59 (8) (1987) 1486e1489.
[13] K.M. Kant, V. Noordhoek Hegt, J.G. Aerts, A patient with four-year survival
after nonsmall cell lung carcinoma with a solitary metachronous small bowel
metastasis, J. Oncol. 2010 (2010) 616130.
